Furthermore, overexpression of GCLC ∆213-424aa also could not reverse shCENPT-mediated inhibitory effect on the progression of RCC (Fig. 5I–L and fig S10I–P) and ferroptosis (Fig. 5M, N). This evidence concerns the gene GCLC and renal cell carcinoma.